CEO of Hyphens Pharma International, Lim See Wah, did not start the company from scratch. First, he worked there. Fresh out of the National University […]
Tag: Healthcare
Hyphens Pharma takes Cerapro® to Europe in Louis Widmer tie-up
Hyphens Pharma has granted Swiss dermatology house Louis Widmer SA the rights to commercialise its Cerapro® MED Skin Barrier Cream across six European countries: Switzerland, […]
Hyphens Pharma extends Metoject reach to Thailand and Cambodia in deepening medac partnership
Hyphens Pharma has extended its partnership with Germany’s medac to include Thailand and Cambodia for the commercialisation of the Metoject subcutaneous autoinjector pen. The territory […]
Hyphens Pharma brings first new acne molecule in 40 years to Southeast Asia
Hyphens Pharma has launched Winlevi® (clascoterone) cream 1% in Singapore and Malaysia, marking the novel acne treatment’s first entry into Southeast Asia. The launch follows […]
CDW and Neoregen Advance Breakthrough LNP Technology to In Vivo Testing Phase
Singapore, 1 April 2025 – CDW Holding Limited, a SGX Mainboard-listed precision components specialist, announced today that its subsidiary ABio, in collaboration with Neoregen Biotech, is […]
Hyphens Pharma Secures Exclusive Rights to Commercialize Metoject® Auto-Injector in Southeast Asia
Singapore, 11 March 2025 – Hyphens Pharma International Limited, Singapore’s leading specialty pharmaceutical group, has entered into an exclusive agreement with Germany’s medac GmbH to commercialize […]
Hyphens Pharma Reports Record FY2024 Results with 26.5% Net Profit Growth and 74% Dividend Increase
Singapore, 25 February 2025 – Hyphens Pharma International Limited, Singapore’s leading specialty pharmaceutical and consumer healthcare group, today announced outstanding financial results for FY2024, achieving record […]
CDW Holding’s Subsidiary ABio Signs Joint R&D Agreement with Neoregen Biotech to Advance Next-Generation Lipid Nanoparticle Technology
Singapore, 20 January 2025 – CDW Holding Limited, a SGX Mainboard-listed precision components and life sciences specialist, today announced that its subsidiary, A Biotech, has signed […]
CDW Holding Announces Breakthroughs in Cancer-Targeting Antibody Research
Singapore, November 13, 2024 – CDW Holding Limited, a SGX Mainboard-listed company headquartered in Hong Kong, today announced significant progress in its biotechnology subsidiary’s antibody […]
Hyphens Pharma Reports Steady Growth in Q3 2024 with 22.1% Revenue Increase for Nine-Month Period
Singapore, 12 November 2024 – Hyphens Pharma Limited, a leading specialty pharmaceutical and consumer healthcare company, today announced its financial results for the third quarter and […]